Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
doi 10.1136/bmj.282.6264.654-b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Multicenter Clinical Study of a Highly Purified Porcine Factor VIII Concentrate [MTI-9002 (Hyate: C)] in Hemophilia a Patients With Inhibitor

Japanese Journal of Thrombosis and Hemostasis
1991English

Prevalence of Inhibitors to Factor VIII After 25 Exposures to Factor VIII Concentrates and/or Blood Products in Persons With Hemophilia A

Journal of Medical Science And Clinical Research
2017English

Reactions to Low-Molecular-Weight Porcine Factor VIII Concentrates.

BMJ
1981English

Management of Coagulation Factor VIII (FVIII) Inhibitors

Thrombosis Research
Hematology
2019English

Identification of a Novel Mutation in the Factor VIII Gene Causing Severe Haemophilia A

BMC Hematology
HematologyMolecular Biology
2018English

Purification and Characterization of a Highly Purified Human Factor VIII Consisting of a Single Type of Polypeptide Chain.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study

British Journal of Haematology
Hematology
2017English

Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Diagnosis of Haemophilia: Use of an Artificial Factor-Viii-Deficient Human Plasma System

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1967English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy